5429192025-04-012025-06-305429192025-06-305429192025-04-012025-06-30in-capmkt:OtherExpenses1Member5429192025-04-012025-06-30ItemsThatWillNotBeReclassifiedToProfitAndLoss15429192025-04-012025-06-30ItemsThatWillNotBeReclassifiedToProfitAndLoss25429192025-06-30Statement15429192025-04-012025-06-30Statement15429192025-06-30StatementDynamic1I1Statement15429192025-06-30StatementDynamic1I2Statement1iso4217:INRxbrli:pureiso4217:INRxbrli:shares542919ARTEMISMEDNOTLISTEDINE025R01021ARTEMIS MEDICARE SERVICES LIMITEDMain BoardEquity2025-04-012026-03-312025-08-052025-07-30INRLakhsQuarterlyFirst quarterSingle segmentHealthcare Services2025-08-0515:15:002025-08-0516:25:00true1falseNo such default2025-04-012025-06-30UnauditedStandalone2497986000695760002567562000636349000003730650007109200010659900010797860002266891000300671000030067100067282000192170008649900002141720000000214172000-38000021379200013893200011.361.35001.361.35The value of Earning per share for the quarter is not annualised. <BR> <BR> Notes: <BR> 1. The above unaudited standalone financial results for the quarter ended June 30, 2025 (financial results) have been reviewed by the Audit Committee and subsequently approved by the Board of Directors of the Company at their respective meetings held on August 05, 2025. The statutory auditors, T R Chadha & Co LLP have expressed an unmodified conclusion on the aforesaid financial results. <BR> <BR> 2. The above financial results have been prepared in accordance with the Companies (Indian Accounting Standards) Rules, 2015, as amended (Ind AS), as prescribed under Section 133 of the Companies Act 2013 (the 'Act') read with the Companies (Indian Accounting Standards) Rules, 2015 (as amended) and the other recognised accounting practices and policies to the extent applicable and is in compliance with presentation and disclosure requirements of Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (as amended). <BR> <BR> 3. The results for the quarter ended March 31, 2025, are the balancing figures between audited figures in respect of full financial year ended March 31, 2025 and published and unaudited results for the nine month period ended December 31, 2024. <BR> <BR> Please refer remaining notes from unaudited financial results filed in PDF format.Other Expenses1079786000Remeasurement gain/(loss) of defined employee benefit plans-1979000Deferred Tax adjustment on revaluation that will not be reclassified to profit or loss1101000-878000-498000-380000Preferential Issues2024-05-1633000000002025-06-30trueCARE RATINGS LIMITEDfalseNot ApplicableNo CommentsNo CommentsSanjiv Kumar KothariChief Financial OfficerGurugram2025-08-05To support acquisition, expansion and capital expenditure requirements of the Company and its subsidiaries (including, by way of investment in its subsidiaries)NOT APPLICABLE320000000005400000000a) During the quarter ended June 30, 2025, the Company has entered into a binding MOU and paid an advance deposit of Rs. 54 Crore to secure its right to enter into a Medical Services Agreement. <br></br> <br></br> b) Pending utilization of funds as per Objects of the Issue, the Company has temporarily parked unutilized amount in Fixed Deposits Receipt with Scheduled Banks.Other general corporate purposesNOT APPLICABLE1000000000794000000a) No amount was utilized during the quarter ended June 30, 2025. <br></br> <br></br> b) Pending utilization of funds as per Objects of the Issue, the Company has temporarily parked unutilized amount in Fixed Deposits Receipt with Scheduled Banks.